Medicine Description betallerge 0.25/2mg
betallerge 0.25/2mg tablets is a medication that combines betamethasone and dexchlorpheniramine maleate to address various allergy-related symptoms. Betamethasone is a potent corticosteroid that functions by suppressing inflammation and modulating the immune response. It inhibits the release of inflammatory mediators and reduces tissue swelling, thereby alleviating symptoms associated with allergic reactions. Dexchlorpheniramine maleate, an antihistamine, works by blocking histamine H1 receptors, thereby mitigating the effects of histamine that can lead to itching, sneezing, and nasal congestion. Together, these components provide a comprehensive approach to managing allergic symptoms.
Indications and Uses of betallerge 0.25/2mg tablets
- Allergic rhinitis
- Allergic conjunctivitis
- Chronic urticaria
- Allergic skin reactions
- Management of symptoms associated with acute allergic reactions
Side Effects of betallerge 0.25/2mg tablets
- Drowsiness
- Dizziness
- Dry mouth
- Fatigue
- Gastrointestinal disturbances
Storage and Handling
Store betallerge tablets at room temperature, away from direct sunlight and moisture. Keep out of reach of children and do not use after the expiration date.
Patient Advice and Precautions
Patients should be advised to avoid activities requiring alertness, such as driving, if drowsiness occurs. Additionally, it is essential to inform healthcare providers of any other medications being taken to prevent potential drug interactions. Those with a history of sensitivity to corticosteroids or antihistamines should use this medication with caution.